PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.\', \'The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.\', \'Research Technologies Branch, Rocky Mountain Laboratories, National Institutes of Health, Hamilton, MT 59840, USA.\', \'Rocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.\', \'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.\', \'Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.\', \'Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA. vincent.munster@nih.gov.\']
?:citedBy
  • -1
?:creator
?:doi
  • eabh075510.1126/scitranslmed.abh0755
?:doi
?:hasPublicationType
?:journal
  • Science translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 34315826
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.7
?:rankingScore_hIndex
  • 147
?:title
  • Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all